1. Home
  2. NXRT vs GPCR Comparison

NXRT vs GPCR Comparison

Compare NXRT & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXRT
  • GPCR
  • Stock Information
  • Founded
  • NXRT 2014
  • GPCR 2016
  • Country
  • NXRT United States
  • GPCR United States
  • Employees
  • NXRT N/A
  • GPCR N/A
  • Industry
  • NXRT Real Estate Investment Trusts
  • GPCR
  • Sector
  • NXRT Real Estate
  • GPCR
  • Exchange
  • NXRT Nasdaq
  • GPCR Nasdaq
  • Market Cap
  • NXRT 957.7M
  • GPCR 1.1B
  • IPO Year
  • NXRT N/A
  • GPCR 2023
  • Fundamental
  • Price
  • NXRT $37.25
  • GPCR $25.57
  • Analyst Decision
  • NXRT Buy
  • GPCR Strong Buy
  • Analyst Count
  • NXRT 6
  • GPCR 9
  • Target Price
  • NXRT $46.33
  • GPCR $78.13
  • AVG Volume (30 Days)
  • NXRT 117.5K
  • GPCR 1.2M
  • Earning Date
  • NXRT 04-29-2025
  • GPCR 05-20-2025
  • Dividend Yield
  • NXRT 5.51%
  • GPCR N/A
  • EPS Growth
  • NXRT N/A
  • GPCR N/A
  • EPS
  • NXRT N/A
  • GPCR N/A
  • Revenue
  • NXRT $255,529,000.00
  • GPCR N/A
  • Revenue This Year
  • NXRT $0.06
  • GPCR N/A
  • Revenue Next Year
  • NXRT $5.96
  • GPCR N/A
  • P/E Ratio
  • NXRT N/A
  • GPCR N/A
  • Revenue Growth
  • NXRT N/A
  • GPCR N/A
  • 52 Week Low
  • NXRT $30.98
  • GPCR $13.22
  • 52 Week High
  • NXRT $48.37
  • GPCR $62.74
  • Technical
  • Relative Strength Index (RSI)
  • NXRT 49.74
  • GPCR 59.07
  • Support Level
  • NXRT $36.87
  • GPCR $25.06
  • Resistance Level
  • NXRT $38.08
  • GPCR $27.50
  • Average True Range (ATR)
  • NXRT 0.89
  • GPCR 1.66
  • MACD
  • NXRT 0.16
  • GPCR 0.20
  • Stochastic Oscillator
  • NXRT 46.33
  • GPCR 54.40

About NXRT NexPoint Residential Trust Inc.

NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: